Pediatric Immune Thrombocytopenia: Advances in Pathophysiology, Diagnosis, Risk-Based Management, and Emerging Therapeutic Strategies
International Journal of Sciences and Innovation Engineering · 04.11.2026 · 3 (11) · 247-252
DOI: 10.70849/ijsci03112681242 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Sciences and Innovation Engineering, online erschienen am 04.11.2026. Verfasst von Muktarali kyzy Begimai und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Pediatric immune thrombocytopenia (ITP) is an acquired autoimmune bleeding disorder characterized by isolated thrombocytopenia resulting from a combination of autoantibody-mediated platelet destruction and impaired thrombopoiesis. While the majority of children experience a self-limiting acute course that resolves within months, a substantial minority progress to persistent or chronic disease.
Objective
This narrative review aims to synthesize contemporary clinical insights, foundational mechanisms, diagnostic pathways, risk-based management strategies, and emerging therapeutic innovations for pediatric ITP.
Conclusion
Management of pediatric ITP has shifted away from aggressive interventions toward a bleeding-centric, risk-adapted approach. The advent of thrombopoietin receptor agonists (TPO-RAs) and novel immunomodulatory strategies has profoundly expanded therapeutic options for refractory cases, minimizing long-term morbidity.
Zitieren
APA
Begimai, M. K., Kumari, P., Deo, R., Jamal, S., & Rashid, S. (2026). Pediatric Immune Thrombocytopenia: Advances in Pathophysiology, Diagnosis, Risk-Based Management, and Emerging Therapeutic Strategies. International Journal of Sciences and Innovation Engineering, 3(11), 247-252. https://doi.org/10.70849/ijsci03112681242
Vancouver
Begimai MK, Kumari P, Deo R, Jamal S, Rashid S. Pediatric Immune Thrombocytopenia: Advances in Pathophysiology, Diagnosis, Risk-Based Management, and Emerging Therapeutic Strategies. International Journal of Sciences and Innovation Engineering. 2026;3(11):247-252. doi:10.70849/ijsci03112681242
BibTeX
@article{Begimai2026,
author = {Begimai, Muktarali kyzy and Kumari, Pallavi and Deo, Rajpriya and Jamal, Sadia and Rashid, Samreen},
title = {Pediatric Immune Thrombocytopenia: Advances in Pathophysiology, Diagnosis, Risk-Based Management, and Emerging Therapeutic Strategies},
journal = {International Journal of Sciences and Innovation Engineering},
year = {2026},
volume = {3},
number = {11},
pages = {247--252},
doi = {10.70849/ijsci03112681242}
}
EUVIMED